| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $32.4M | -43.2% |
| SG&A Expense | $13.0M | -33.0% |
| Operating Income | -$45.4M | +40.6% |
| Income Tax | $0 | — |
| Net Income | -$42.1M | +43.0% |
| EPS (Basic) | -$8.87 | -395.5% |
| EPS (Diluted) | -$8.87 | -395.5% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $140.7M | +929.5% |
| Current Assets | $208.9M | +12.5% |
| Total Assets | $210.3M | +8.6% |
| Current Liabilities | $5.0M | -56.4% |
| Total Liabilities | $5.3M | -61.5% |
| Stockholders' Equity | $205.0M | +13.9% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$28.1M | +53.9% |
| Capital Expenditures | $56K | -98.2% |
| Investing Cash Flow | $3.8M | -93.1% |
| Financing Cash Flow | $156.7M | — |
| Free Cash Flow | -$28.1M | +56.0% |